Bjarnason Agnar, Westin Johan, Lindh Magnus, Andersson Lars-Magnus, Kristinsson Karl G, Löve Arthur, Baldursson Olafur, Gottfredsson Magnus
Faculty of Medicine, University of Iceland, Reykjavik.
Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden.
Open Forum Infect Dis. 2018 Feb 8;5(2):ofy010. doi: 10.1093/ofid/ofy010. eCollection 2018 Feb.
The microbial etiology of community-acquired pneumonia (CAP) is often unclear in clinical practice, and previous studies have produced variable results. Population-based studies examining etiology and incidence are lacking. This study examined the incidence and etiology of CAP requiring hospitalization in a population-based cohort as well as risk factors and outcomes for specific etiologies.
Consecutive admissions due to CAP in Reykjavik, Iceland were studied. Etiologic testing was performed with cultures, urine-antigen detection, and polymerase chain reaction analysis of airway samples. Outcomes were length of stay, intensive care unit admission, assisted ventilation, and mortality.
The inclusion rate was 95%. The incidence of CAP requiring hospitalization was 20.6 cases per 10000 adults/year. A potential pathogen was detected in 52% (164 of 310) of admissions and in 74% (43 of 58) with complete sample sets. was the most common pathogen (61 of 310, 20%; incidence: 4.1/10000). Viruses were identified in 15% (47 of 310; incidence: 3.1/10000), were identified in 12% (36 of 310; incidence: 2.4/10000), and multiple pathogens were identified in 10% (30 of 310; incidence: 2.0/10000). Recent antimicrobial therapy was associated with increased detection of ( < .001), whereas a lack of recent antimicrobial therapy was associated with increased detection of ( = .02). Symptoms and outcomes were similar irrespective of microbial etiology.
Pneumococci, , and viruses are the most common pathogens associated with CAP requiring hospital admission, and they all have a similar incidence that increases with age. Symptoms do not correlate with specific agents, and outcomes are similar irrespective of pathogens identified.
在临床实践中,社区获得性肺炎(CAP)的微生物病因常常不明确,以往的研究结果也不尽相同。缺乏基于人群的病因学和发病率研究。本研究调查了基于人群队列中需要住院治疗的CAP的发病率和病因,以及特定病因的危险因素和结局。
对冰岛雷克雅未克因CAP连续入院的患者进行研究。采用培养、尿抗原检测和气道样本的聚合酶链反应分析进行病因学检测。结局指标包括住院时间、重症监护病房入住率、辅助通气和死亡率。
纳入率为95%。需要住院治疗的CAP发病率为每10000名成年人每年20.6例。在310例入院患者中有52%(164例)检测到潜在病原体,在58例有完整样本集的患者中有74%(43例)检测到潜在病原体。肺炎链球菌是最常见的病原体(310例中有61例,占20%;发病率:4.1/10000)。病毒在15%(310例中有47例;发病率:3.1/10000)中被鉴定出来,肺炎支原体在12%(310例中有36例;发病率:2.4/10000)中被鉴定出来,多种病原体在10%(310例中有30例;发病率:2.0/10000)中被鉴定出来。近期使用抗菌药物与肺炎链球菌检测增加相关(P<0.001),而近期未使用抗菌药物与肺炎支原体检测增加相关(P=0.02)。无论微生物病因如何,症状和结局相似。
肺炎球菌、肺炎支原体和病毒是与需要住院治疗的CAP相关的最常见病原体,它们的发病率相似且均随年龄增长而增加。症状与特定病原体无关,无论鉴定出何种病原体,结局相似。